Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Synapse. 2017 Oct 7;72(1):10.1002/syn.22012. doi: 10.1002/syn.22012

Figure 4. Blood pressure and heart rate in WT mice treated with YIL781.

Figure 4

(A, B) Treatment with different doses of the GHSR1a antagonist YIL781 did not change either blood pressure (n=3, ANOVA for treatment P=0.60) or heart rate (n=3, ANOVA for treatment P=0.80) compared to vehicle treatment in WT mice.